Search
Gimatecan
go.drugbank.com/drugs/DB06721InvestigationalGimatecan is an orally available 7-t-butoxyiminomethyl-substituted lipophilic camptothecin derivative.
Nocodazole
go.drugbank.com/drugs/DB08313ExperimentalNocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.
Aminorex
go.drugbank.com/drugs/DB01490ExperimentalIllicitAminorex is an amphetamine-like anorectic agent. It may cause pulmonary hypertension.
Oxfenicine
go.drugbank.com/drugs/DB04291ExperimentalOxfenicine in an inhibitor of myocardial metabolism of nonesterified fatty acids (NEFA).
Synonyms: L-2-(p-hydroxyphenyl)glycineD-Lysine
go.drugbank.com/drugs/DB03252ExperimentalAn essential amino acid. It is often added to animal feed. [PubChem]
Synonyms: D-Lysin, D-LysineParamethasone
go.drugbank.com/drugs/DB01384ExperimentalA glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-reta...
Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 SubstratesCrotalus adamanteus antivenin
go.drugbank.com/drugs/DB13893ApprovedEach year it is estimated there are 45,000 snakebites in the US and 300,000 to 400,000 bites worldwide. About 8000 of these snakebites involve venomous snake species. The majority of people bitten are males and about 50% occur in the age...
Dalfampridine
go.drugbank.com/drugs/DB06637ApprovedInvestigationalDalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.
Synonyms: p-AminopyridineCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 SubstratesTeduglutide
go.drugbank.com/drugs/DB08900ApprovedInvestigationalTeduglutide is a glucagon-like peptide-2 (GLP-2) analogue. It is made up of 33 amino acids and is manufactured using a strain of Escherichia coli modified by recombinant DNA technology. Teduglutide differs from GLP-2 by one amino acid (a...
Gefitinib
go.drugbank.com/drugs/DB00317ApprovedInvestigationalGefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is ma...
Categories: P-glycoprotein inhibitors, P-glycoprotein substrates